Longview
Longview

Investment Committee

Every acquisition auto-generates a memo — inputs, stress cases, concentration impacts, and approvals archived forever.

LS-12314 approved

IC Memo — LS-12314

Auto-generated from the policy master record · fictional data

archived
Face value
$5M
Purchase price
$1.1M
21.6% of face
Life expectancy
62 mo
Annual premium
$128K
Total expected basis
$1.7M
purchase + premiums to LE
Modeled base IRR
14.8%
Stress +24 months
8.7%
above the 8% floor
Carrier
Sovereign Life
A++
Portfolio impact after acquisition
11.7%
Carrier concentration
limit 15%
+0.3%
Age concentration
within band
+0.1%
State concentration
within band
Recommendation

Acquire at or below $1.08M. Pricing is 21.6% of face vs 23.7% portfolio average; carrier and state concentration remain inside limits; stress IRR stays above the 8% floor. Approval and inputs archived to the IC ledger.

Approval trail

Permanently archived — the trail auditors, LPs, and regulators actually want

CIO
Sep 18, 2026
Approve
Head of Underwriting
Sep 18, 2026
Approve
Compliance
Sep 19, 2026
Approve — file complete